{"id":167694,"date":"2023-07-17T10:24:10","date_gmt":"2023-07-17T15:24:10","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2023\/07\/the-prognostic-value-of-pcsk9-levels-for-predicting-major-adverse-cardiovascular-events-and-mortality-in-diabetics"},"modified":"2023-07-17T10:24:10","modified_gmt":"2023-07-17T15:24:10","slug":"the-prognostic-value-of-pcsk9-levels-for-predicting-major-adverse-cardiovascular-events-and-mortality-in-diabetics","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2023\/07\/the-prognostic-value-of-pcsk9-levels-for-predicting-major-adverse-cardiovascular-events-and-mortality-in-diabetics","title":{"rendered":"The prognostic value of PCSK9 levels for predicting major adverse cardiovascular events and mortality in diabetics"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/the-prognostic-value-of-pcsk9-levels-for-predicting-major-adverse-cardiovascular-events-and-mortality-in-diabetics2.jpg\"><\/a><\/p>\n<p>Globally, atherosclerotic cardiovascular disease (ASCVD) is the primary cause of illness and death and is much more common in with type 2 diabetes mellitus (T2DM) patients than non-diabetic individuals. Nevertheless, for approximately ten years, the identification of distinct prognostic risk biomarkers remains challenging.<\/p>\n<p>In a recent study posted to the preprint server <em><a href=\"https:\/\/www.researchsquare.com\/article\/rs-3142712\/v1\" rel=\"noopener\">Research Square<\/a> <\/em>while under review for publication in <em>Cardiovascular Diabetology<\/em>, researchers investigate the prognostic value of serum proprotein convertase subtilisin\/kexin type 9 (PCSK9) levels in T2DM patients to predict all-cause mortality and major adverse cardiovascular events (MACE).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Globally, atherosclerotic cardiovascular disease (ASCVD) is the primary cause of illness and death and is much more common in with type 2 diabetes mellitus (T2DM) patients than non-diabetic individuals. Nevertheless, for approximately ten years, the identification of distinct prognostic risk biomarkers remains challenging. In a recent study posted to the preprint server Research Square while [\u2026]<\/p>\n","protected":false},"author":396,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-167694","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/167694","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/396"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=167694"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/167694\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=167694"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=167694"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=167694"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}